SK23896A3 - Alkoxy-substituted beta-carbolines, a method of their producing, their use and drugs containing these substances - Google Patents

Alkoxy-substituted beta-carbolines, a method of their producing, their use and drugs containing these substances Download PDF

Info

Publication number
SK23896A3
SK23896A3 SK238-96A SK23896A SK23896A3 SK 23896 A3 SK23896 A3 SK 23896A3 SK 23896 A SK23896 A SK 23896A SK 23896 A3 SK23896 A3 SK 23896A3
Authority
SK
Slovakia
Prior art keywords
group
carbon atoms
formula
alkoxy
alkyl
Prior art date
Application number
SK238-96A
Other languages
English (en)
Slovak (sk)
Inventor
Dieter Seidelmann
Lechoslaw Turski
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of SK23896A3 publication Critical patent/SK23896A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK238-96A 1993-08-31 1994-08-29 Alkoxy-substituted beta-carbolines, a method of their producing, their use and drugs containing these substances SK23896A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4330175A DE4330175A1 (de) 1993-08-31 1993-08-31 Alkoxy-substituierte beta-Carboline
PCT/DE1994/001009 WO1995006647A1 (de) 1993-08-31 1994-08-29 ALKOXY-SUBSTITUIERTE β-CARBOLINE MIT EINWIRKUNG AUF DEN AMPA-REZEPTOR

Publications (1)

Publication Number Publication Date
SK23896A3 true SK23896A3 (en) 1996-11-06

Family

ID=6497015

Family Applications (1)

Application Number Title Priority Date Filing Date
SK238-96A SK23896A3 (en) 1993-08-31 1994-08-29 Alkoxy-substituted beta-carbolines, a method of their producing, their use and drugs containing these substances

Country Status (17)

Country Link
EP (1) EP0716657A1 (ja)
JP (1) JPH09501938A (ja)
KR (1) KR960704888A (ja)
CN (1) CN1129938A (ja)
AU (1) AU7530394A (ja)
CA (1) CA2170615A1 (ja)
CZ (1) CZ50596A3 (ja)
DE (1) DE4330175A1 (ja)
FI (1) FI960940A0 (ja)
HU (1) HUT73845A (ja)
IL (1) IL110745A0 (ja)
NO (1) NO960812L (ja)
NZ (1) NZ271615A (ja)
PL (1) PL313230A1 (ja)
SK (1) SK23896A3 (ja)
WO (1) WO1995006647A1 (ja)
ZA (1) ZA946670B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY125942A (en) 1999-09-07 2006-09-29 Upjohn Co Aminoalkoxy carbazoles for the treatment of cns diseases
IL283725B2 (en) 2017-06-20 2024-04-01 Imbria Pharmaceuticals Inc Compositions and methods for increasing efficiency of cardiac metabolism
EP3866794B1 (en) 2018-10-17 2024-12-04 Imbria Pharmaceuticals, Inc. Methods of treating rheumatic diseases using trimetazidine-based compounds
EP3976101A4 (en) 2019-05-31 2023-06-21 Imbria Pharmaceuticals, Inc. FIBROSIS TREATMENT METHODS USING COMPOUNDS THAT PROMOTE GLUCOSE OXIDATION
US11780811B2 (en) 2020-06-30 2023-10-10 Imbria Pharmaceuticals, Inc. Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US11530184B2 (en) 2020-06-30 2022-12-20 Imbria Pharmaceuticals, Inc. Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US11883396B2 (en) 2021-05-03 2024-01-30 Imbria Pharmaceuticals, Inc. Methods of treating kidney conditions using modified forms of trimetazidine

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57123180A (en) * 1980-12-17 1982-07-31 Schering Ag 3-substituted beta-carboline, manufacture and psychotropic drug containing same
DE3545776A1 (de) * 1985-12-20 1987-06-25 Schering Ag 5-aminoalkyl-ss-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel
DE3608089A1 (de) * 1986-03-08 1987-09-10 Schering Ag Heteroaryl-oxy-ss-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel
AU619203B2 (en) * 1987-08-28 1992-01-23 Schering Aktiengesellschaft Isoxazole-beta-carboline derivatives
DE3943225A1 (de) * 1989-12-23 1991-06-27 Schering Ag Neue ss-carboline, verfahren zu deren herstellung und deren verwendung in arzneimitteln
US5350750A (en) * 1991-04-27 1994-09-27 Schering Aktiengesellschaft β-carboline-3-hydroxyalkylcarboxylic acid ester derivatives, process for their production and their use in pharmaceutical agents
DE4118741A1 (de) * 1991-06-05 1992-12-10 Schering Ag Neue hetaryloxy-(beta)-carboline, deren herstellung und verwendung in arzneimitteln
DE4120109A1 (de) * 1991-06-15 1992-12-17 Schering Ag 3-aryl- oder 3-hetaryl-(beta)-carboline, deren herstellung und verwendung in arzneimitteln
DE4130933A1 (de) * 1991-09-13 1993-03-18 Schering Ag Neue (beta)-carbolinderivate, deren herstellung und verwendung in arzneimitteln
DE4212529A1 (de) * 1992-04-10 1993-10-14 Schering Ag Verwendung von µ-Carbolinen als nicht-kompetitive Glutamat-Antagonisten

Also Published As

Publication number Publication date
NO960812D0 (no) 1996-02-28
FI960940L (fi) 1996-02-28
EP0716657A1 (de) 1996-06-19
NZ271615A (en) 1996-09-25
IL110745A0 (en) 1994-11-11
CZ50596A3 (en) 1996-06-12
NO960812L (no) 1996-02-28
CA2170615A1 (en) 1995-03-09
WO1995006647A1 (de) 1995-03-09
HUT73845A (en) 1996-09-30
FI960940A7 (fi) 1996-02-28
PL313230A1 (en) 1996-06-10
FI960940A0 (fi) 1996-02-28
KR960704888A (ko) 1996-10-09
JPH09501938A (ja) 1997-02-25
CN1129938A (zh) 1996-08-28
HU9600505D0 (en) 1996-04-29
DE4330175A1 (de) 1995-03-02
ZA946670B (en) 1995-04-21
AU7530394A (en) 1995-03-22

Similar Documents

Publication Publication Date Title
RU2308458C2 (ru) Антагонисты рецептора cgrp
US7557112B2 (en) Aromatic-ring-fused pyrimidine derivative
AU2016276806B2 (en) Tricyclic derivative compound, method for preparing same, and pharmaceutical composition comprising same
US7947690B2 (en) Pyrimidine derivative condensed with a non-aromatic ring
US6812234B2 (en) Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
CA2902103C (en) Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
DE60315265T2 (de) Stickstoffhaltige heterocyclische verbindung und arzneimittel davon
US6498170B2 (en) Cyclamine sulfonamides as β-3 adrenergic receptor agonists
US20100234415A1 (en) Indole derivatives as crth2 receptor antagonists
HU211705A9 (en) Piperidine compounds, their preparation and use
AU2003286701A1 (en) Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity
JPWO2002068407A1 (ja) ベンゾイミダゾール化合物
HU198036B (en) Process for production of derivatives of 3-piperidil-/1h/-indasole and medical preparatives containing them
CA3179059A1 (en) Collagen 1 translation inhibitors and methods of use thereof
JP6585718B2 (ja) 抗ヒスタミン剤としての新規ベンゾイミダゾール誘導体
SK23896A3 (en) Alkoxy-substituted beta-carbolines, a method of their producing, their use and drugs containing these substances
CA3245085A1 (en) HETEROCYCLIC DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM
HUT68212A (en) Process for producing new beta-carbolines and pharmaceutical compositions which are applicable for treatment of neurological and psychiatric disorders and containing beta-carbolines
CN119866329A (zh) 用于治疗亨廷顿氏病的杂环化合物
JPWO2005097782A1 (ja) ピペリジン誘導体
WO1996033169A1 (en) 1-[φ-(3,4-DIHYDRO-2-NAPHTHALENYL)ALKYL] CYCLIC AMINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, AND MEDICINAL COMPOSITION CONTAINING THE SAME
WO2025173981A1 (ko) 대사성 질환을 위한 아미노알콜 유도체
HK40023781A (en) Substituted azacycles as muscarinic m1 receptor positive allosteric modulators